US equities |
MU $877.55 ▲+0.00% TSLA $372.22 ▲+0.00% SNDK $1,238.03 ▲+0.00% NBIS $158.74 ▲+0.00% SPCX $147.49 ▲+0.00% NVDA $210.96 ▲+0.00% AMD $516.79 ▲+0.00% INTC $86.96 ▲+0.00%
FinancialContent

Palisade Bio, Inc. - Common Stock (NQ:PALI)

1.330 UNCHANGED
Delayed Quote Updated: 4:00 PM EDT, Oct 23, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Palisade Bio, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗
 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Monday's Intraday Session ↗
 
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Dow Falls 300 Points On Last Trading Session of 2022; S&P 500 Down 1% ↗
U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping around 300 points on Friday. 
Via Benzinga
News headline image
Palisade Bio Voluntarily Ceases Enrollment In Its Lead Program Study ↗
 
Via Benzinga
News headline image
Why Is Palisade Bio (PALI) Stock Up 130% Today? ↗
Today's rally in PALI stock appears to be tied directly to an FDA announcement that it's fast tracking a key drug from the company. 
Via InvestorPlace
News headline image
12 Health Care Stocks Moving In Friday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Silo Pharma Shares Are Trading Higher By Around 64%? Here Are 46 Stocks Moving In Friday's Mid-Day Session ↗
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares jumped 121% to $0.4428 after the company requested to withdraw its registration on Form S-1 and said it does not intend to pursue the... 
Via Benzinga
News headline image
Stocks Firmly On Track For Worst Year Since 2008 ↗
The last day of 2022 is offering no reprieve to investors, with the major indexes still on track for their worst year since 2008, after months of persistent inflation and aggressive interest rate... 
Via Talk Markets
News headline image
Nasdaq Falls 100 Points; Dermata Therapeutics Shares Surge ↗
U.S. stocks traded lower midway through trading, with the Nasdaq Composite dropping around 100 points on Friday. 
Via Benzinga
News headline image
US Stocks Open Lower; Dow Drops 250 Points ↗
U.S. stocks traded lower this morning, with the Dow Jones dropping around 250 points on Friday. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Dermata Therapeutics Shares Are Trading Higher By Over 100%; Here Are 21 Stocks Moving Premarket ↗
Gainers Dermata Therapeutics, Inc. (NASDAQ: DRMA) shares rose 105% to $0.41 in pre-market trading after the company requested to withdraw its registration on Form S-1 and said it does not intend to... 
Via Benzinga
News headline image
Why Hoth Therapeutics Shares Are Trading Higher By More Than 130%? Here Are 60 Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Hoth Therapeutics, Inc. (NASDAQ: HOTH) shares jumped 131.5% to $10.19 after the FDA accepted the IND application for HT-001. 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session ↗
 
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session ↗
 
Via Benzinga
News headline image
Stocks That Hit 52-Week Lows On Tuesday ↗
  On Tuesday, 298 companies achieved new lows for the year. 
Via Benzinga
News headline image
Peering Into Palisade Bio's Recent Short Interest ↗
Palisade Bio's (NASDAQ:PALI) short percent of float has risen 14313.64% since its last report. The company recently reported that it has 428 thousand shares sold short, which is 31.71% of all regular... 
Via Benzinga
News headline image
Palisade Bio Announces Early Exercise of Warrants Resulting in Cash Proceeds of $1.25 Million
From Palisade Bio, Inc.
Via GlobeNewswire
News headline image
Palisade Bio Regains Compliance with Nasdaq Listing Requirements
From Palisade Bio, Inc.
Via GlobeNewswire
News headline image
Why Manchester United Shares Are Trading Higher By Around 10%; Here Are 20 Stocks Moving Premarket ↗
Gainers COMSovereign Holding Corp. (NASDAQ: COMS) shares rose 58.4% to $0.1069 in pre-market trading after gaining more than 16% on Tuesday. 
Via Benzinga
News headline image
Why American Eagle Outfitters Shares Climbed Over 18%; Here Are 78 Biggest Movers From Yesterday ↗
Gainers Cosmos Holdings Inc. (NASDAQ: COSM) jumped 86.9% to close at $0.3275 on Tuesday after jumping 21% on Monday. Cosmos Health agreed to sell its Sky Premium Life Luxury food supplement brand on... 
Via Benzinga
News headline image
Dow Jumps Over 300 Points; S&P 500 Rises 1% ↗
U.S. stocks traded higher toward the end of trading, with the Dow Jones gaining more than 300 points on Tuesday. 
Via Benzinga
News headline image
Why Dollar Tree Shares Are Trading Lower By 10%? Here Are 53 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Palisade Bio, Inc. (NASDAQ: PALI) shares jumped 99.1% to $4.42 after the company announced the FDA granted Fast Track designation to LB1148 for the acceleration of time to return of bowel... 
Via Benzinga
News headline image
Palisade Bio (NASDAQ: PALI) Awarded Fast Track Designation from U.S. FDA for LB1148
Palisade Bio, Inc. (NASDAQ: PALI) is engaged as a biopharmaceutical company, which is focused on the research and development of 
Via Spotlight Growth
News headline image
Crude Oil Surges 2%; Best Buy Posts Upbeat Earnings ↗
U.S. stocks traded higher midway through trading, with the Dow Jones gaining more than 250 points on Tuesday. 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
US Stocks Open Higher As Dow Surges 250 Points ↗
U.S. stocks traded higher this morning, with the Dow Jones gaining around 250 points on Tuesday. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >